RxSight (NASDAQ:RXST) Price Target Cut to $22.00 by Analysts at Wells Fargo & Company
RxSight (NASDAQ:RXST – Free Report) had its price objective trimmed by Wells Fargo & Company from $35.00 to $22.00 in a report released on Thursday,Benzinga reports. The brokerage currently has an equal weight rating on the stock. Several other equities research analysts have also recently issued reports on the stock. Needham & Company LLC restated […]
RxSight (NASDAQ:RXST – Free Report) had its price objective trimmed by Wells Fargo & Company from $35.00 to $22.00 in a report released on Thursday,Benzinga reports. The brokerage currently has an equal weight rating on the stock. Several other equities research analysts have also recently issued reports on the stock. Needham & Company LLC restated […]
